Intervention1: Test Product: Paliperidone Palmitate Prolonged-Release Injectable Suspension (PP-PRIS

2 trials

Sponsors

Tolmar International Ltd

Conditions

Health Condition 1: F209- Schizophrenia, unspecified

Unknown Phase

Generic drug trial seeking for approval of generic paliperidone 1 month injection for treatment of Schizophrenia.

Active, not recruitingCTRI/2019/06/019832

Tolmar International LtdHealth Condition 1: F209- Schizophrenia, unspecified

Target: 320Updated: 2021-11-24

Generic drug trial to seek approval for Paliperidone 1 month injection for treatment of Schizophrenia.

Active, not recruitingCTRI/2019/06/019840

Tolmar International LtdHealth Condition 1: F209- Schizophrenia, unspecified

Target: 320Updated: 2021-11-24